A recent study by Xing et al. (37) demonstrated that SA could enhance ferroptosis via the NRF2/cystine-glutamate antiporter (xCT)/glutathione peroxidase 4 (GPX4) pathway, and thus inhibit the growth of HCC both in vitro and in vivo. The gene discussed is GPX4; the disease is hepatocellular carcinoma.